US Patent 9995753 Anti-pembrolizumab antibodies
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+366 characters)
Article
Patent abstract
The present invention provides antibodies and antigen-binding fragments thereof that bind to the antibody pembrolizumab (pembrolizumab). These antibodies are useful, for example, for use as positive controls in assays for detecting the presence of anti-drug antibodies in a sample, e.g., the blood of a patient who has been administered pembrolizumab.
Edits on 12 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09995753 Anti-pembrolizumab antibodies US Patent 9995753 Anti-pembrolizumab antibodies
Infobox
Patent Number
0999575300
Patent Number
999575300
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
099957530
Date of Patent
June 12, 2018
0Patent Application Number
152743300
Date Filed
September 23, 2016
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
099957530
Date of Patent
June 12, 2018
0Patent Application Number
152743300
Date Filed
September 23, 2016
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09995753 Anti-pembrolizumab antibodies
Infobox
Is a
Patent jurisdiction
Patent number
09995753
Date of patent
June 12, 2018
Patent application number
15274330
Date Filed
September 23, 2016
Patent primary examiner
Find more entities like US Patent 9995753 Anti-pembrolizumab antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
